Quote:
Originally Posted by Birgitta-A
Hi All,
Now they are reporting trials with the first telomerase inhibitor called Imetelstat. They try the drug on patients with two hematological cancers - Essential Thrombocythemia and Multiple Myeloma. You have to register.
http://jpmorgan.metameetings.com/web...hp?ticker=GERN
Kind regards
Birgitta-A
|
This fights cancer cells, but would hurt those of us who want our normal telomeres to grow longer. Correct? That means they need a way to target the cancer cells.